China Inherited Metabolic Disorders Testing Market (2025-2031) | Size & Revenue, Industry, Value, Share, Trends, Segmentation, Analysis, Competitive Landscape, Outlook, Forecast, Companies, Growth

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 China Country Macro Economic Indicators

3.2 China Inherited Metabolic Disorders Testing Market Revenues & Volume, 2021 & 2031F

3.3 China Inherited Metabolic Disorders Testing Market - Industry Life Cycle

3.4 China Inherited Metabolic Disorders Testing Market - Porter's Five Forces

3.5 China Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F

3.6 China Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F

3.7 China Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 China Inherited Metabolic Disorders Testing Market Revenues & Volume Share, By End-user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness and diagnosis of inherited metabolic disorders in China

4.2.2 Growing demand for early detection and personalized treatment options

4.2.3 Technological advancements in genetic testing and diagnostic tools

4.3 Market Restraints

4.3.1 Limited access to specialized testing facilities and expertise in certain regions of China

4.3.2 High cost associated with genetic testing and treatment for inherited metabolic disorders

4.3.3 Regulatory challenges and slow approval processes for new testing technologies

6.1 China Inherited Metabolic Disorders Testing Market, By Disease Type

6.1.1 Overview and Analysis

6.1.2 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Disease Type, 2021- 2031F

6.1.3 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Hurler Syndrome, 2021- 2031F

6.1.4 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Niemann-Pick Disease, 2021- 2031F

6.1.5 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Tay-Sachs Disease, 2021- 2031F

6.1.6 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Gaucher Disease, 2021- 2031F

6.1.7 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Fabry Disease, 2021- 2031F

6.1.8 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Krabbe Disease, 2021- 2031F

6.2 China Inherited Metabolic Disorders Testing Market, By Therapy Type

6.2.1 Overview and Analysis

6.2.2 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Enzyme Replacement Therapy, 2021- 2031F

6.2.3 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Cellular Transplantation, 2021- 2031F

6.2.4 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Small Molecule Based Therapy, 2021- 2031F

6.2.5 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Substrate Reduction Therapy, 2021- 2031F

6.2.6 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.2.7 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Drug Therapy, 2021- 2031F

6.3 China Inherited Metabolic Disorders Testing Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.4 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Others, 2021- 2031F

6.4 China Inherited Metabolic Disorders Testing Market, By End-user

6.4.1 Overview and Analysis

6.4.2 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Hospital and Clinics, 2021- 2031F

6.4.3 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F

6.4.4 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Blood Banks, 2021- 2031F

6.4.5 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F

6.4.6 China Inherited Metabolic Disorders Testing Market Revenues & Volume, By Others, 2021- 2031F

7.1 China Inherited Metabolic Disorders Testing Market Export to Major Countries

7.2 China Inherited Metabolic Disorders Testing Market Imports from Major Countries

8.1 Number of newborn screening programs implemented in China

8.2 Adoption rate of next-generation sequencing (NGS) for inherited metabolic disorder testing

8.3 Percentage of healthcare providers trained in genetic counseling for inherited metabolic disorders

9.1 China Inherited Metabolic Disorders Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F

9.2 China Inherited Metabolic Disorders Testing Market Opportunity Assessment, By Therapy Type, 2021 & 2031F

9.3 China Inherited Metabolic Disorders Testing Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 China Inherited Metabolic Disorders Testing Market Opportunity Assessment, By End-user, 2021 & 2031F

10.1 China Inherited Metabolic Disorders Testing Market Revenue Share, By Companies, 2024

10.2 China Inherited Metabolic Disorders Testing Market Competitive Benchmarking, By Operating and Technical Parameters